⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited KingdomNasdaqGS

KNSA

Kiniksa Pharmaceuticals International, plc

Healthcare · Drug Manufacturers - Specialty & Generic

76.73USD

-4.0600 (-5.03%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on KNSA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.31▲$0.3122
Next quarter$0.3$0.322
Current year$1.17▲$1.1612
Next year$1.63▼$1.712

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.29$0.3+0.02 (+5.3%)
2026-03-31$0.16$0.27+0.11 (+68.8%)
2025-12-31$0.4$0.17-0.23 (-57.3%)
2025-09-30$0.37$0.23-0.14 (-37.3%)

Wall Street coverage

48 ratings from 12 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Goldman SachsMaintainedBuy$75 $90Jul 30, 2026
JP MorganMaintainedOverweight$72 $107Jul 29, 2026
Canaccord GenuityMaintainedBuy$64 $98Jul 29, 2026
WedbushMaintainedOutperform$72 $99Jul 29, 2026
CitigroupMaintainedBuy$60 $100Jul 29, 2026
Goldman SachsMaintainedBuy$60 $75Jul 23, 2026
Wells FargoMaintainedOverweight$57 $74Jul 13, 2026
WedbushMaintainedOutperform$59 $72Jun 29, 2026
Canaccord GenuityMaintainedBuy$62 $64Apr 29, 2026
CitigroupMaintainedBuy$50 $60Apr 29, 2026
WedbushMaintainedOutperform$58 $59Apr 29, 2026
Wells FargoMaintainedOverweight$53 $57Apr 29, 2026
JefferiesMaintainedBuy$58 $71Apr 28, 2026
WedbushMaintainedOutperform$53 $58Apr 16, 2026
Wells FargoMaintainedOverweight$50 $53Feb 25, 2026
WedbushMaintainedOutperform$50 $53Feb 25, 2026
Canaccord GenuityInitiatedBuy$62Feb 19, 2026
WedbushMaintainedOutperform$48 $50Jan 13, 2026
Goldman SachsMaintainedBuy$45 $55Oct 29, 2025
CitigroupMaintainedBuy$45 $50Oct 17, 2025
WedbushMaintainedOutperform$38 $44Oct 13, 2025
TD CowenInitiatedBuy$60Sep 29, 2025
Wells FargoMaintainedOverweight$42 $45Sep 25, 2025
JefferiesMaintainedBuy$45 $54Jul 29, 2025
Wells FargoMaintainedOverweight$30 $42Jul 9, 2025

Insider transactions

215 filings from 19 insiders · 21 buy / 6 sell over 6m

Officers and directors of KNSA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Megna Michael ROfficer, CHIEF ACCOUNTING OFFICERSell4.6k$80.30$369kSep 3, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExerciseRestricted Share Unit2.5k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExerciseRestricted Share Unit1.6k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExerciseRestricted Share Unit1.7k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExerciseRestricted Share Unit2.5k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERGrantShare Option37.0k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERGrantRestricted Share Unit9.3k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERTax4.0k$79.28$318kSep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExercise2.5k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExercise1.7k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExercise1.6k——Sep 1, 2026
Moat RossOfficer, CHIEF OPERATING OFFICERExercise2.5k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERExerciseRestricted Share Unit2.7k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERExerciseRestricted Share Unit1.8k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERExerciseRestricted Share Unit1.6k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERExerciseRestricted Share Unit3.1k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERGrantShare Option31.1k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERGrantRestricted Share Unit7.8k——Sep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERTax4.4k$79.28$349kSep 1, 2026
Ragosa MarkOfficer, CHIEF FINANCIAL OFFICERExercise3.1k——Sep 1, 2026

Analyst Notes

Sign in to write

No analyst notes on KNSA yet.

Analyst Ratings

8 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current17000Buy1.88
1 mo ago17000Buy1.88
2 mo ago17000Buy1.88
3 mo ago17000Buy1.88
Price target$98.00$87.00 – $108.00
+27.7% to target

Top voices on KNSA

Members whose judged calls on KNSA have played out most reliably.

No settled calls on KNSA yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice